Navigation Links
New Research May Pave the Way for Shorter Hospital Stays for Diabetes Patients

Protocol-driven insulin therapy on the medical-surgical wards resulted in better glucose control, as compared to individualized management// in patients with diabetic foot ulcers. As a result, shorter hospital stay may be possible.

“This is the first randomized pilot trial to showcase how intensive subcutaneous insulin protocol on medical-surgical wards can help to improve diabetes control,” Alicia Leung, MD, at Stroger Hospital of Cook County in Chicago said. “Diabetes clinical pathway applied to routine management of surgical patients on the wards of public hospitals resulted in superior glucose control.”

A group of 23 patients with type 2 Diabetes Mellitus were admitted for surgical management of diabetic foot ulcers. Once routine medical consultation for preoperative evaluation of high glucose was requested, patients were randomly assigned to a medical consult physician providing individualized glycemic management or medical consult physician trained in protocol-driven subcutaneous insulin therapy twice a day.

“Those patients that received the protocol-driven insulin therapy were in the hospital roughly 2.5 days less than those who received the individualized glycemic management, discharge decisions being made by a surgical team based on wound healing and regardless of glucose control”, Dr. Leung said. “This clinically significant difference eventually supported implementation of hospital-wide subcutaneous insulin protocol at Stroger Hospital, limiting the size of our study - thus we were able to show only a marginal statistical significance. Optimal glucose control is known to improve wound healing and also make diabetic patients less susceptible to bacterial infections.”

"Our study shows that protocol-driven insulin therapy results in a better glycemic outcome, improving the quality of care and achieving standard of care goals,” Dr. Leung said.

“Endocrinology expertise is important in implementin g and trouble-shooting insulin protocol, identifying patients that do not fit standard care,” Dr. Jurado, currently a hospitalist at Saint Lukes Hospital in Jacksonville, FL, said. “However, hyperglycemia being the fourth most common co-morbid condition in the hospital, clinical pathways for glucose management can be successfully delivered by hospitalists and house staff physicians.”

Source-Newwise
SRM
'"/>




Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... ... The Touchpoint Solution’s new neuroscience wearable, Buzzies, generated over $100K in sales online ... $25,000 on Kickstarter to bring to the market what people are calling ... inventor, says she feels like she stumbled upon a miracle that she wants other ...
(Date:12/6/2016)... ... ... Of the variety of ingredients in the food supply, few spark more ... beliefs that hot dogs include “everything but the oink,” today’s wieners are made from ... meat and poultry in a hot dog recipe can add flavor, keep hot dogs ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and high schools ... apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. The application ... receive up to $3,000. , The grant is named after California Casualty ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... charity, is thrilled to formally announce its Not a Moment to Lose fundraising ... Lose will rally supporters dedicated to declaring victory over cancer. The campaign aims ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  Nearly 30 million people in ... the epidemic of diabetes. 1 However, nearly 40% ... glucose levels (hyperglycemia) and significant glucose variability. 2 These ... including cardiovascular events. If left untreated, hyperglycemia can lead ... disease or blindness. 3 As part ...
(Date:12/6/2016)... 6, 2016   Sienna Biopharmaceuticals, Inc. ... and aesthetics company, today announced it has ... pharmaceutical company focused on developing first-in-class topical ... psoriasis, atopic dermatitis and pruritus (itch). Under ... make an undisclosed upfront payment in cash ...
(Date:12/6/2016)... 6, 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... focused on the development of novel therapies for ... U.S. Food and Drug Administration (FDA) has granted ... of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, ... selectively regulates the expression of genes believed to ...
Breaking Medicine Technology: